- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03466008
Whole-Body Cryotherapy (WBC) as an Adjunct Treatment on Pain in Fibromyalgia Persons: Short Time Effect.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Fibromyalgia diagnosis
Exclusion Criteria:
cardiorespiratory disorder current pregnancy cold intolerance Embolic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Whole body cryotherapy arm
intervention consisted of 10 sessions of WBC (three minutes for each session) which were performed in addition to usual care in a standard cryotherapy room over a duration of 8 days.
|
10 sessions of WBC were performed (in addition to usual care) in a standard cryotherapy room over a duration of 8 days.
Other Names:
|
No Intervention: Usual treatment arm
usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain status at 1 month from baseline
Time Frame: change from baseline at one month follow-ups
|
pain score on a numerical scale (Subjective Numerical scale) likert rating 0 to 10 by the fibromyalgia patient 0 indicate no pain, 10 maximal pain value
|
change from baseline at one month follow-ups
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain status at 2 weeks from baseline
Time Frame: change from baseline at two weeks follow-ups
|
pain score on a Subjective Numerical scale 0 to 10; likert rating 0 to 10 by the fibromyalgia patient 0 indicate no pain, 10 maximal pain value
|
change from baseline at two weeks follow-ups
|
functional status : the Oswestry Disability Index (ODI), subjective low back pain questionnaire
Time Frame: chnage from baseline at two weeks follow-ups
|
Patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain There are 10 questions (items). The questions are designed in a way that to realize how the back or leg pain is affecting the patient's ability to manage in everyday life. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. The obtained score can be multiplied by 2 to produce a percentage score. If the first statement is marked, the section score = 0, If the last statement is marked, it = 5 If all ten sections are completed the score is calculated as followed: Example: 10 (total score of the patient), 50 (total possible raw score), 10/50 x 100 = 20% If one section is missed or not applicable, the score is calculated as followed: Example: 15 (total score of the patient), 45 (total possible score), 15/45 x 100 = 30% |
chnage from baseline at two weeks follow-ups
|
functional status : the Oswestry Disability Index (ODI)
Time Frame: change from baseline at one month follow-ups
|
Patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain There are 10 questions (items). The questions are designed in a way that to realize how the back or leg pain is affecting the patient's ability to manage in everyday life. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. The obtained score can be multiplied by 2 to produce a percentage score. If the first statement is marked, the section score = 0, If the last statement is marked, it = 5 If all ten sections are completed the score is calculated as followed: Example: 10 (total score of the patient), 50 (total possible raw score), 10/50 x 100 = 20% If one section is missed or not applicable, the score is calculated as followed: Example: 15 (total score of the patient), 45 (total possible score), 15/45 x 100 = 30% |
change from baseline at one month follow-ups
|
functional status : the Disability of the Arm, Shoulder and Hand (DASH) score
Time Frame: change from baseline at one month follow-ups
|
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities.
This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale.
DASH Scoring Formula = ([(sum of n responses)/n] -1)(25) where n represents the number of completed items.
The score on both test ranges from 0 (no disability) to 100 (most severe disability).Minimal Detectable Change (MDC) is between 12.75% - 17.23%
|
change from baseline at one month follow-ups
|
functional status : Lower Extremity Functional Scale (LEFS)
Time Frame: change from baseline at one month follow-ups
|
The test can be used to evaluate the impairment of a patient with lower extremity musculoskeletal condition or disorders.
Can be used clinically to measure the patients' initial function, ongoing progress, and outcome as well as to set functional goals.In 1999, Binkley et al. developed the Lower Extremity Functional Scale (LEFS), a patient-reported lower limb function questionnaire applicable to a wide spectrum of outpatients with a lower limb musculoskeletal condition.
The LEFS consists of 20 items, each scored on a 5-point scale (0 to 4).
The total score varies from 0 to 80, with higher scores representing better a functional status.
|
change from baseline at one month follow-ups
|
health related quality of life (HRQoL)
Time Frame: change from baseline to one month follow-ups
|
physical functioning (PCS) and mental functioning (MCS) from the SF-36 questionnaire The score on both test ranges from 0 (poor health related quality of life) to 100 (better health related quality of life value)
|
change from baseline to one month follow-ups
|
Collaborators and Investigators
Investigators
- Study Director: guillaume polidori, Pr, University of Reims
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B039201629783
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
-
Yousra Hisham Abdel FattahCompletedFibromyalgia, PrimaryEgypt
-
Forest LaboratoriesCypress Bioscience, Inc.TerminatedPrimary FibromyalgiaUnited States
-
Universidade Federal do Rio Grande do NorteCompleted
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
University of ManitobaCompleted
Clinical Trials on Whole-Body Cryotherapy
-
Pomeranian Medical University SzczecinCompletedMultiple Sclerosis (ICD10-G35) | Surface Electromyography | Whole-body Cryotherapy
-
Tecnología e Innovación Médico Estética S.L.Completed
-
Istituto Auxologico ItalianoCompleted
-
University Hospital, MontpellierCryoMed MillenaireRecruitingBreast Cancer | Aromatase InhibitorsFrance
-
Helsinki University Central HospitalTurku University Hospital; Novo Nordisk A/SCompleted
-
Gazi UniversityGulhane Training and Research HospitalRecruitingArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
Federal University of Health Science of Porto AlegreCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
The Hong Kong Polytechnic UniversityUnknown
-
Federal University of Health Science of Porto AlegreLeonhardt Ventures LLCNot yet recruiting